Neueon Corporation up 10.2% on board approval for ₹300 crore fundraise

According to the filing dated September 23, 2026 (page 1), the Board of Directors, at its meeting held the same day, “considered and approved” several key items:

1. Fundraise of up to ₹ 300 crore
   The board agreed to recommend, for shareholder approval, the raising of funds “by way of issuance of such number of equity shares having face value of ₹ 1 each of the Company and / or other eligible securities or any combination thereof… for an aggregate amount not exceeding ₹ 300 crore or an equivalent amount thereof.”

   Annexure‑I (page 3) clarifies that:

   • The securities will be equity shares and / or other eligible securities “in one or more tranches”.
   • The issuance can be via “any permissible modes, including but not limited to a private placement, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws”.
   • The total size is “upto an aggregate amount not exceeding Rs. 300 crore or an equivalent amount thereof (inclusive of such premium as may be fixed on such Securities) in one or more tranches”.

   Crucially, the filing does not specify an issue price, investor names, timing of tranches or an exact instrument mix. Those details will be determined later, subject to market conditions and regulatory limits.

2. Delegation to a Management Committee
   The board also approved “Delegation of Powers to the Management Committee for the Issue and Allotment of Equity Shares and/or Other Eligible Securities for Raising of Funds up to ₹300 Crore.”
   This means execution authority for the raise—structuring, timing and allotment—will sit with a smaller committee, allowing the company to move faster once approvals are in place.

3. Alteration of Articles of Association
   The board resolved to recommend an alteration of the Articles of Association. Annexure‑II (page 4) states that the company proposes to “amend/ substitute article no. 22(i) of Article of Association of the Company.”

   The new Article 22(i) would read:

   “The Board may, from time to time, make calls upon the members in respect of any monies unpaid on their Shares (whether on account of the nominal value of the Shares or by way of premium) and not by the conditions of allotment thereof made payable at fixed times:
   Provided that the Board may make one, two, or multiple calls, and that no such call shall be payable less than 15 days from the date fixed for payment of the last preceding call.”

   This language tightens and clarifies the board’s power to make calls on any unpaid amount on partly paid shares, including premium, and sets a minimum gap between successive calls.

The board also approved a postal ballot route to get shareholder consent for the key items (page 2):

• “Approval of material related party transactions for the year 2026-27;”
• “Raising capital from eligible investors through an issuance of equity shares and/or other eligible securities;”
• “Alteration of the Articles of Association of the company.”

The company will use remote e‑voting only. Annexure‑III (page 5) lays out the calendar of events:

• Board approval and appointment of scrutinizer: September 23, 2026.
• Cut‑off date for mailing the postal ballot notice: September 23, 2026.
• Dispatch of postal ballot notice by email: by September 29, 2026.
• Publication of newspaper advertisement: by September 30, 2026.
• E‑voting start: September 30, 2026 (9:00 am).
• E‑voting end: October 29, 2026 (5:00 pm).
• Declaration of results: “within 2 working days of the closure of voting.”

M/s. RPR & Associates, Practicing Company Secretaries, have been appointed as the scrutinizer “to scrutinize the Postal Ballot process through remote e-Voting in fair and transparent manner” (page 2).

The filing itself does not contain any revenue, profit, margin or guidance numbers. It is purely a corporate action update. The market read points to the ₹ 300 crore fundraising plan as the key driver of the 10.2% move.

Neueon is a small-cap with a history of operating losses and negative net worth, as highlighted in prior commentary. Against that backdrop, investors appear to be treating the board’s approval of a sizeable raise as a potential survival and repair step:

• A successful raise of up to Rs. 300 crore could help address liabilities, support working capital and fund any restructuring or new projects.
• The explicit authority to make calls on unpaid share capital (through the revised Article 22(i)) aligns the legal framework with the possibility of partly paid instruments or structured equity, which often feature in turnaround capital structures.

At the same time, the filing makes it clear that the raise will be via equity shares and/or other securities, which implies meaningful dilution for existing shareholders if the full amount is raised. The market’s positive reaction suggests that, at the current scale and financial stress, participants are willing to trade off dilution for a stronger balance sheet.

For investors trying to model the impact, several key pieces are still missing from the public record:

• No breakdown of how the Rs. 300 crore will be used (debt repayment vs. growth capex vs. working capital).
• No indication of the exact instrument mix (pure equity vs. convertibles or other eligible securities).
• No pricing, floor price or band for any proposed issue.
• No updated financials, margins or forward-looking guidance alongside this announcement.

That lack of detail means the 10.2% move to Rs 13.71 is being driven by the idea of a capital lifeline rather than a fully specified transaction. The eventual terms—issue price, investor quality and utilisation of proceeds—will determine whether this rally has legs or proves to be a short-term reaction to the headline size of the raise.

Neueon’s board has set the stage for a potentially transformative Rs. 300 crore capital raise and aligned its Articles and shareholder approvals to support that plan. The stock’s jump reflects the market’s focus on balance sheet repair potential in a company with a weak financial base, even as the precise contours of dilution and deployment are yet to be disclosed.